Adaptive Phage Therapeutics, Inc.
MD · Founded 2017 · CIK 0001701259 · Biotech · Acquired
Bacteriophage manufacturing and purification platform for phage therapy
adaptive.ai →- Grants
- $297K
- 1 award
- Sector median: 1
- Raised
- $45M
- 6 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 2 granted · 38 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $765,000 | |
| Private capital raised | Form D · SEC | $2,350,000 | |
| Private capital raised | Form D · SEC | $2,825,000 | |
| Private capital raised | Form D · SEC | $3,350,000 | |
| Private capital raised | Form D · SEC | $23,262,000 | |
| Federal grant | Department of Health and Human Services · N43 · Development of a Rapid and Scalable Method for Bacteriophage Manufacture and Purification | $296,787 | |
| Private capital raised | Form D · SEC | $11,999,999 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1148 | Vulcan Biologics, Inc. | — | — |
| 1149 | VERISIM LIFE, INC. | — | — |
| 1150 | PAFOSPHARMA, LLC | — | — |
| 1151 | Adaptive Phage Therapeutics, Inc. | — | $45M |
| 1152 | SERION, INC. | — | — |
| 1153 | THERASOURCE, LLC | — | — |
| 1154 | LOHOCLA RESEARCH CORPORATION | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Subhendu BasuExecutive Officer
- Jesse GoodmanDirector
- Ian HardyDirector
- Martin HeideckerDirector
- Jana JensenDirector
- Jonathan LeffDirector
- Evan LohDirector
- Raymond MartzDirector
- Carl MerrilDirector · Executive Officer
- Gregory MerrilDirector · Executive Officer · Promoter
- William MutrynDirector
- Michael OrndorffExecutive Officer
Patents
- Phage Dispensing Systemapplication
- Method For Purification Of Bacteriophage Particlesapplication
- Method For Purification Of Bacteriophage Particlesgranted
- Improved Anti-biofilm Assay Methodsapplication
- Phage Dispensing Systemapplication
- Phage Dispensing Systemgranted
- Computer Implemented Method For Analyzing Host Phage Response Dataapplication
- System And Method To Select Phage Therapy Based On Time And Locationapplication
- Machine Learning System For Interpreting Host Phage Responseapplication
- Novel Methods Of Vaccination Using Icosahedral Phageapplication
- Monitoring Host Cell Contamination Of Virus-based Biological Productsapplication
- Preservation Of Phage Concentration In Clinical Samplesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.